電気生理市場：製品別（EPアブレーションカテーテル、EPラボラトリーデバイス、EP診断カテーテル、アクセスデバイス、その他）、適応症別（心房細動（AF）、心房粗動、ウォルフ-パーキンソン-ホワイト症候群（WPW）、房室結節再列頻拍（AVNRT）、その他）、エンドユーザー（病院・心臓センター、一般外科手術センター、その他）。世界の機会分析および産業予測、2021-2030年

Electrophysiology Market by Product (EP Ablation Catheters, EP Laboratory Devices, EP Diagnostic Catheters, Access Devices, and Others), Indication (Atrial Fibrillation (AF), Atrial Flutter, Wolff-Parkinson-White Syndrome (WPW), Atrioventricular Nodal Reentry Tachycardia (AVNRT), and Others), and End User (Hospitals & Cardiac Centers, Ambulatory Surgery Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

電気生理の世界市場は、2020年に64億9,970万ドル、2021年から2030年にかけて年平均成長率14.4％で成長し、2030年には226億5,140万ドルに達すると予測されています。電気生理学とは、心拍の機能を導く電気信号... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年1月1日	US$6,168 シングルユーザーライセンスライセンス・価格情報・注文方法はこちら	270	英語

サマリー

電気生理の世界市場は、2020年に64億9,970万ドル、2021年から2030年にかけて年平均成長率14.4％で成長し、2030年には226億5,140万ドルに達すると予測されています。

電気生理学とは、心拍の機能を導く電気信号経路の仕組みと性能を研究する学問と定義されています。心臓の電気システムの正常な機能を妨げる心臓組織の領域を特定することで、心臓の不整脈を診断するために使用される手順である。また、電気生理学的装置は、カテーテルを用いて心臓の異常組織を外科的に除去することにより、心房細動を治療するように設計されています。

電気生理学の世界市場の成長は、心房細動や心房粗動などの心臓不整脈の有病率の驚くべき増加、電気生理学機器の取り扱いや使用に関する医師や電気生理学者の知識を普及させるための政府の取り組みの増加、および心臓アブレーション手術数の急増が主な要因となっています。例えば、次世代医療機器企業であるAPNヘルス社は、2021年に米国で約75万件の心臓電気生理アブレーション処置が実施されたと報告しており、さらに同ソースによると、2021年には約30万件数のカテーテルアブレーション処置が心房細動に対して実施されていることも確認されている。さらに、2021年8月には、大手医療機器再処理部門の一つであるMedline ReNewalが、心臓電気生理学の臨床医が心臓電気生理学実験室の処置の基礎についてより多くを学ぶための継続教育コースシリーズの立ち上げを発表しています。

また、電気生理用カテーテルの開発技術の進歩や、電気生理用製品の強化に向けた戦略的協定の増加も、世界の電気生理市場を牽引する大きな要因となっています。例えば、2022年1月、大手ヘルスケアテクノロジー企業の1つであるMedtronic, Inc.は、Affera, Inc.と高度な心臓アブレーション製品およびアクセサリーのポートフォリオを強化するための契約を締結したと発表しています。さらに、糖尿病、心血管疾患、高血圧などの慢性疾患の有病率の増加は、市場の成長に大きく寄与しています。

さらに、老年人口が増加していることも市場の成長を後押ししています。これは、老年人口が加齢により心房細動などの心疾患にかかりやすく、より良い健康状態を得るために様々な電気生理カテーテルの需要を高めることに起因しています。米国国立慢性疾患予防・健康増進センターによると、65歳以上の人口の約9％が心房細動と診断されていると報告されています。このことは、世界の電気生理市場の成長に大きく貢献すると考えられます。

アブレーションカテーテルや診断用カテーテルなどの電気生理機器の承認数の増加が、世界市場の主要な推進力となっています。また、各国政府や民間団体による心臓病センターや医療インフラへの資金提供の増加が、市場の成長を後押しすると期待されています。また、医療費の増加や、先進的かつ革新的なデバイスを製造する主要企業の増加により、市場拡大のための有利な機会が提供されると考えられます。

しかし、電気生理機器にかかるコストは高く、市場成長の妨げとなっています。一方、心臓焼灼術に関する臨床研究の増加は、電気生理学市場の成長を増大させます。例えば、2020年、ジョンソン＆ジョンソンの系列会社であるバイオセンス・ウェブスターは、持続性心房細動の進行を遅らせるために、ラジオ波（RF）アブレーション処置と抗不整脈療法単独との間の結果を評価するためのアルテプラーゼ・テネクトプラーゼ試験評価（ATTEST）臨床試験を実施しました。その結果、発作性から持続性心房細動と診断された患者さんにおいて、RFアブレーションは薬物治療よりも有効であると結論づけられました。この結果、多くの主要企業が新興国市場に参入し、電気生理学市場の拡大に向けた好機が到来しています。
世界の電気生理市場は、製品、適応症、エンドユーザー、地域に分類されます。製品別では、EPアブレーションカテーテル、EPラボラトリーデバイス、EP診断カテーテル、アクセスデバイス、その他に分類されます。適応症別では、心房細動（AF）、心房粗動、ウォルフ・パーキンソン-ホワイト症候群（WPW）、房室結節性リエントリー頻拍（AVNRT）、その他に細分化されています。エンドユーザー別では、病院・心臓センター、外来手術センター、その他に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAに分かれて分析されています。

電気生理学の世界市場で事業を展開している主な企業には、Abbott Laboratories、Biotronik SE & Co.KG、Boston Scientific Corporation、CardioFocus, Inc、GE Healthcare、Koninklijke Philips N.V.、Johnson & Johnson, Inc、Medtronic Plc、MicroPort Scientific Corporation、Siemens Healthineers AGが挙げられます。

ステークホルダーにとっての主なメリット

本レポートは、世界の電気生理市場規模を現在の動向と将来予測とともに詳細に分析し、差し迫った投資ポケットを解明するものです。
2021年から2030年までの市場分析を提供しており、利害関係者が市場に存在する機会を活用することを可能にすると期待されます。
地域に関する包括的な分析は、地域市場を理解し、戦略的な事業計画を促進し、優勢な機会を決定するのに役立ちます。
主要企業のプロファイルと成長戦略を徹底的に分析し、世界の電気生理学市場の競争展望を理解します。

主要市場セグメント
#製品別
##EP アブレーションカテーテル
###クリオアブレーションEPカテーテル
###ラジオ波焼灼カテーテル
####イリゲーテッドチップ高周波焼灼カテーテル
####従来型ラジオ波焼灼カテーテル
###マイクロ波焼灼装置
###レーザーアブレーションシステム
###ナビゲーショナルアドバンスマッピングアクセサリー
##EPラボラトリー機器
###EP X線装置
###3Dマッピングシステム
###EPレコーディングシステム
###EPリモートステアリングシステム
###EPリモートステアリングシステム
###その他
##EP診断用カテーテル
###従来型EP診断用カテーテル
####ステアラブル診断用カテーテル
####固定式診断用カテーテル
###アドバンスドEP診断カテーテル
###超音波診断用カテーテル
##アクセス機器
##その他

#適応症別
##心房細動(AF)
#心房粗動
##ウォルフ・パーキンソン-ホワイト症候群(WPW)
#房室結節リエントリー頻拍 (AVNRT)
##その他
#エンドユーザー別
##病院・心臓病センター
##外来手術センター
##その他

#地域別
##北米
###米国
###カナダ
###メキシコ
##ヨーロッパ
###ドイツ
###フランス
###イギリス
###イタリア
###ヨーロッパ以外の地域
##アジア太平洋
###日本
###中国
###オーストラリア
###インド
###その他のアジア太平洋地域
#ラメア
###ブラジル
###サウジアラビア
###南アフリカ
###LAMEAの残りの地域

主要な市場関係者
#アボット・ラボラトリーズ
#Biotronik SE & Co.KG
#ボストン・サイエンティフィック・コーポレーション
#カーディオフォーカス社
#GEヘルスケア
#Koninklijke Philips N.V.
#ジョンソン・エンド・ジョンソン株式会社
#メドトロニック・ピーエルシー
#マイクロポートサイエンティフィック株式会社
#シーメンス・ヘルヒネアーズAG

ページTOPに戻る

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of cardiac arrhythmia
3.5.1.2.Increase in demand for minimally invasive procedures
3.5.1.3.Advancements in technology in the field of electrophysiology
3.5.1.4.Increase in number of approvals for electrophysiology devices

3.5.2.Restraint

3.5.2.1.High cost of electrophysiological devices

3.5.3.Opportunities

3.5.3.1.Increase in number of key players to manufacture advanced electrophysiology devices
3.5.3.2.Lucrative opportunities in emerging market

3.5.4.Impact analysis

3.6.Impact analysis of COVID-19 on the electrophysiology market

CHAPTER 4:ELECTROPHYSIOLOGY MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.EP ablation catheters

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.EP Ablation Catheters, by type
4.2.2.1.Market size and forecast
4.2.2.2.Cryoablation EP catheters

4.2.2.2.1.Market size and forecast

4.2.2.3.Radiofrequency ablation catheters

4.2.2.3.1.Market size and forecast

4.2.2.3.1.1.Market size and forecast

4.2.2.3.2.Irrigated-tip radiofrequency ablation catheters

4.2.2.3.2.1.Market size and forecast

4.2.2.3.3.Conventional radiofrequency ablation catheters

4.2.2.3.3.1.Market size and forecast

4.2.2.4.Microwave ablation systems

4.2.2.4.1.Market size and forecast

4.2.2.5.Laser ablation systems

4.2.2.5.1.Market size and forecast

4.2.2.6.Navigational advanced mapping accessories

4.2.2.6.1.Market size and forecast

4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country

4.3.EP laboratory devices

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.EP laboratory devices, by type

4.3.2.1.Market size and forecast
4.3.2.2.EP X-Ray systems

4.3.2.2.1.Market size and forecast

4.3.2.3.3D mapping systems

4.3.2.3.1.Market size and forecast

4.3.2.4.EP recording systems

4.3.2.4.1.Market size and forecast

4.3.2.5.EP remote steering systems

4.3.2.5.1.Market size and forecast

4.3.2.6.Others

4.3.2.6.1.Market size and forecast

4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country

4.4.EP diagnostic catheters

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.EP Diagnostic Catheters, by type

4.4.2.1.Market size and forecast
4.4.2.2.Conventional EP diagnostic catheters
4.4.2.2.1.Market size and forecast
4.4.2.2.2.Steerable diagnostic catheters

4.4.2.2.2.1.Market size and forecast

4.4.2.2.3.Fixed diagnostic catheters

4.4.2.2.3.1.Market size and forecast

4.4.2.3.Advanced EP diagnostic catheters

4.4.2.3.1.Market size and forecast

4.4.2.4.Ultrasound EP diagnostic catheters

4.4.2.4.1.Market size and forecast

4.4.3.Market size and forecast, by region
4.4.4.Market analysis, by country

4.5.Access devices

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country

4.6.Others

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country

CHAPTER 5:ELECTROPHYSIOLOGY MARKET, BY INDICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Atrial fibrillation (AF)

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Atrial flutter

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

5.4.Wolff-Parkinson-White Syndrome (WPW)

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country

5.5.Atrioventricular Nodal Reentry Tachycardia (AVNRT)

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market analysis, by country

5.6.Others

5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast, by region
5.6.3.Market analysis, by country

CHAPTER 6:ELECTROPHYSIOLOGY MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals & cardiac centers

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.Ambulatory surgery centers

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

6.4.Others

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country

CHAPTER 7:ELECTROPHYSIOLOGY MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America electrophysiology market, by product
7.2.3.North America electrophysiology market, by indication
7.2.4.North America electrophysiology market, by end user
7.2.5.Market size and forecast, by country

7.2.5.1.U.S.

7.2.5.1.1.U.S. electrophysiology market, by product
7.2.5.1.2.U.S. electrophysiology market, by indication
7.2.5.1.3.U.S. electrophysiology market, by end user

7.2.5.2.Canada

7.2.5.2.1.Canada electrophysiology market, by product
7.2.5.2.2.Canada electrophysiology market, by indication
7.2.5.2.3.Canada electrophysiology market, by end user

7.2.5.3.Mexico

7.2.5.3.1.Mexico electrophysiology market, by product
7.2.5.3.2.Mexico electrophysiology market, by indication
7.2.5.3.3.Mexico electrophysiology market, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe electrophysiology market, by product
7.3.3.Europe electrophysiology market, by indication
7.3.4.Europe electrophysiology market, by end user
7.3.5.Market size and forecast, by country

7.3.5.1.Germany

7.3.5.1.1.Germany electrophysiology market, by product
7.3.5.1.2.Germany electrophysiology market, by indication
7.3.5.1.3.Germany electrophysiology market, by end user

7.3.5.2.France

7.3.5.2.1.France electrophysiology market, by product
7.3.5.2.2.France electrophysiology market, by indication
7.3.5.2.3.France electrophysiology market, by end user

7.3.5.3.UK

7.3.5.3.1.UK electrophysiology market, by product
7.3.5.3.2.UK electrophysiology market, by indication
7.3.5.3.3.UK electrophysiology market, by end user

7.3.5.4.Italy

7.3.5.4.1.Italy electrophysiology market, by product
7.3.5.4.2.Italy electrophysiology market, by indication
7.3.5.4.3.Italy electrophysiology market, by end user

7.3.5.5.Rest of Europe

7.3.5.5.1.Rest of Europe electrophysiology market, by product
7.3.5.5.2.Rest of Europe electrophysiology market, by indication
7.3.5.5.3.Rest of Europe electrophysiology market, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific electrophysiology market, by product
7.4.3.Asia-Pacific electrophysiology market, by indication
7.4.4.Asia-Pacific electrophysiology market, by end user
7.4.5.Market size and forecast, by country
The Asia-Pacific electrophysiology market was valued at $1,522.2 million in 2020, and is projected to reach $5,640.2 million by 2030, registering a CAGR of 15.1%. Japan was the highest revenue contributor with $684.1 million in 2020, and is estimated to reach $2,538.1 Million by 2030, registering a CAGR of 15.1% . India is estimated to reach $710.7 million by 2030, at a significant CAGR of 15.9%. Japan and China collectively accounted for around 68.8% share in 2020, with the former constituting around 44.9% share. India and Australia are expected to witness considerable CAGRs of 15.9% and 15.3%, respectively, during the forecast period. The cumulative share of these two regions was 24.7% in 2020, and is anticipated to reach 25.8% by 2030.

7.4.5.1.Japan

7.4.5.1.1.Japan electrophysiology market, by product
7.4.5.1.2.Japan electrophysiology market, by indication
7.4.5.1.3.Japan electrophysiology market, by end user

7.4.5.2.China

7.4.5.2.1.China electrophysiology market, by product
7.4.5.2.2.China electrophysiology market, by indication
7.4.5.2.3.China electrophysiology market, by end user

7.4.5.3.Australia

7.4.5.3.1.Australia electrophysiology market, by product
7.4.5.3.2.Australia electrophysiology market, by indication
7.4.5.3.3.Australia electrophysiology market, by end user

7.4.5.4.India

7.4.5.4.1.India electrophysiology market, by product
7.4.5.4.2.India electrophysiology market, by indication
7.4.5.4.3.India electrophysiology market, by end user

7.4.5.5.Rest of Asia-Pacific

7.4.5.5.1.Rest of Asia-Pacific electrophysiology market, by product
7.4.5.5.2.Rest of Asia-Pacific electrophysiology market, by indication
7.4.5.5.3.Rest of Asia-Pacific electrophysiology market, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA electrophysiology market, by product
7.5.3.LAMEA electrophysiology market, by indication
7.5.4.LAMEA electrophysiology market, by end user
7.5.5.Market size and forecast, by country

7.5.5.1.Brazil

7.5.5.1.1.Brazil electrophysiology market, by product
7.5.5.1.2.Brazil electrophysiology market, by indication
7.5.5.1.3.Brazil electrophysiology market, by end user

7.5.5.2.Saudi Arabia

7.5.5.2.1.Saudi Arabia electrophysiology market, by product
7.5.5.2.2.Saudi Arabia electrophysiology market, by indication
7.5.5.2.3.Saudi Arabia electrophysiology market, by end user

7.5.5.3.South Africa

7.5.5.3.1.South Africa electrophysiology market, by product
7.5.5.3.2.South Africa electrophysiology market, by indication
7.5.5.3.3.South Africa electrophysiology market, by end user

7.5.5.4.Rest of LAMEA

7.5.5.4.1.Rest of LAMEA electrophysiology market, by product
7.5.5.4.2.Rest of LAMEA electrophysiology market, by indication
7.5.5.4.3.Rest of LAMEA electrophysiology market, by end user

CHAPTER 8:COMPANY PROFILES

8.1.ABBOTT LABORATORIES

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.Biotronik SE & Co. KG

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments

8.3.BOSTON SCIENTIFIC CORPORATION

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments

8.4.CardioFocus, Inc.

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Key strategic moves and developments

8.5.GE Healthcare

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance

8.6.Koninklijke Philips N.V.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments

8.7.Johnson & Johnson Services, Inc.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance

8.8.Medtronic plc. (Zephyr Technology Corporation)

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.MICROPORT SCIENTIFIC CORPORATION

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments

8.10.Siemens Healthineers AG

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance

List of Tables

LIST OF TABLES

TABLE 01.ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 02.EP ABLATION CATHETERS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 03.RADIOFREQUENCY ABLATION CATHETERS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 04.EP ABLATION CATHETERS ELECTROPHYSIOLOGY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 05.EP LABORATORY DEVICES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 06.EP LABORATORY DEVICES ELECTROPHYSIOLOGY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 07.EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 08.CONVENTIONAL EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 09.EP DIAGNOSTIC CATHETERS ELECTROPHYSIOLOGY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 10.ACCESS DEVICES ELECTROPHYSIOLOGY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 11.OTHERS ELECTROPHYSIOLOGY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 12.ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 13.ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION (AF), BY REGION, 2020–2030 ($MILLION)
TABLE 14.ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY REGION, 2020–2030 ($MILLION)
TABLE 15.ELECTROPHYSIOLOGYMARKET FOR WOLFF-PARKINSON-WHITE SYNDROME (WPW) , BY REGION, 2020–2030 ($MILLION)
TABLE 16.ELECTROPHYSIOLOGYMARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT) , BY REGION, 2020–2030 ($MILLION)
TABLE 17.ELECTROPHYSIOLOGYMARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 18.ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 19.ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 20.ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 21.ELECTROPHYSIOLOGY MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 22.ELECTROPHYSIOLOGY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 23.NORTH AMERICA ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 24.NORTH AMERICA ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 25.NORTH AMERICA ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 26.NORTH AMERICA ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 27.U.S. ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 28.U.S. ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 29.U.S. ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 30.CANADA ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 31.CANADA ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 32.CANADA ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 33.MEXICO ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 34.MEXICO ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 35.MEXICO ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 36.EUROPE ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 37.EUROPE ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 38.EUROPE ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 39.EUROPE ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 40.GERMANY ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 41.GERMANY ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 42.GERMANY ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 43.FRANCE ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 44.FRANCE ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 45.FRANCE ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 46.UK ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 47.UK ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 48.UK ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 49.ITALY ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 50.ITALY ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 51.ITALY ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 52.REST OF EUROPE ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 53.REST OF EUROPE ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 54.REST OF EUROPE ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 55.ASIA-PACIFIC ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 56.ASIA-PACIFIC ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 57.ASIA-PACIFIC ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 58.ASIA-PACIFIC ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 59.JAPAN ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 60.JAPAN ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 61.JAPAN ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 62.CHINA ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 63.CHINA ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 64.CHINA ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 65.AUSTRALIA ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 66.AUSTRALIA ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 67.AUSTRALIA ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 68.INDIA ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 69.INDIA ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 70.INDIA ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 73.REST OF ASIA-PACIFIC ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 74.LAMEA ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 75.LAMEA ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 76.LAMEA ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 77.LAMEA ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 78.BRAZIL ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 79.BRAZIL ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 80.BRAZIL ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 81.SAUDI ARABIA ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 82.SAUDI ARABIA ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 83.SAUDI ARABIA ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 84.SOUTH AFRICA ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 85.SOUTH AFRICA ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 86.SOUTH AFRICA ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 87.REST OF LAMEA ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 88.REST OF LAMEA ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020–2030 ($MILLION)
TABLE 89.REST OF LAMEA ELECTROPHYSIOLOGY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 90.ABBOTT: COMPANY SNAPSHOT
TABLE 91.ABBOTT: OPERATING SEGMENT
TABLE 92.ABBOTT: PRODUCT PORTFOLIO
TABLE 93.ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 94.BIOTRONIK: COMPANY SNAPSHOT
TABLE 95.BIOTRONIK: OERATING SEGMENT
TABLE 96.BIOTRONIK: PRODUCT PORTFOLIO
TABLE 97.BIOTRONIK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 98.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 99.BOSTON SCIENTIFIC: OERATING SEGMENT
TABLE 100.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 101.BOSTON SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 102.CARDIOFOCUS: COMPANY SNAPSHOT
TABLE 103.CARDIOFOCUS: OERATING SEGMENT
TABLE 104.CARDIOFOCUS: PRODUCT PORTFOLIO
TABLE 105.CARDIOFOCUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106.GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 107.GE HEALTHCARE: OERATING SEGMENT
TABLE 108.GE HEALTHCARE : PRODUCT PORTFOLIO
TABLE 109.PHILIPS: COMPANY SNAPSHOT
TABLE 110.PHILIPS: OPERATING SEGMENTS
TABLE 111.PHILIPS: PRODUCT PORTFOLIO
TABLE 112.PHILIPS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 113.J&J: COMPANY SNAPSHOT
TABLE 114.J&J: OPERATING BUSINESS SEGMENTS
TABLE 115.J&J: PRODUCT PORTFOLIO
TABLE 116.MEDTRONIC: COMPANY SNAPSHOT
TABLE 117.MEDTRONIC: OPERATING SEGMENTS
TABLE 118.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 119.MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 120.MICROPORT: COMPANY SNAPSHOT
TABLE 121.MICROPORT: OERATING SEGMENT
TABLE 122.MICROPORT: PRODUCT PORTFOLIO
TABLE 123.MICROPORT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124.SIEMENS: COMPANY SNAPSHOT
TABLE 125.SIEMENS: OERATING SEGMENT
TABLE 126.SIEMENS: PRODUCT PORTFOLIO

List of Figures

LIST OF FIGURES

FIGURE 01.ELECTROPHYSIOLOGY MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019–2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.ELECTROPHYSIOLOGY MARKET FOR CRYOABLATION EP CATHETERS, 2020–2030 ($MILLION)
FIGURE 14.ELECTROPHYSIOLOGY MARKET FOR RADIOFREQUENCY ABLATION CATHETERS, 2020–2030 ($MILLION)
FIGURE 15.ELECTROPHYSIOLOGY MARKET FOR IRRIGATED-TIP RADIOFREQUENCY ABLATION CATHETERS, 2020–2030 ($MILLION)
FIGURE 16.ELECTROPHYSIOLOGY MARKET FOR CONVENTIONAL RADIOFREQUENCY ABLATION CATHETERS, 2020–2030 ($MILLION)
FIGURE 17.ELECTROPHYSIOLOGY MARKET FOR MICROWAVE ABLATION SYSTEMS, 2020–2030 ($MILLION)
FIGURE 18.ELECTROPHYSIOLOGY MARKET FOR LASER ABLATION SYSTEMS, 2020–2030 ($MILLION)
FIGURE 19.ELECTROPHYSIOLOGY MARKET FOR NAVIGATIONAL ADVANCED MAPPING ACCESSORIES, 2020–2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF EP ABLATION CATHETERS ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2020–2030 (%)
FIGURE 21.ELECTROPHYSIOLOGY MARKET FOR EP X-RAY SYSTEMS, 2020–2030 ($MILLION)
FIGURE 22.ELECTROPHYSIOLOGY MARKET FOR 3D MAPPING SYSTEMS, 2020–2030 ($MILLION)
FIGURE 23.ELECTROPHYSIOLOGY MARKET FOR EP RECORDING SYSTEMS, 2020–2030 ($MILLION)
FIGURE 24.ELECTROPHYSIOLOGY MARKET FOR EP REMOTE STEERING SYSTEMS, 2020–2030 ($MILLION)
FIGURE 25.ELECTROPHYSIOLOGY MARKET FOR OTHERS, 2020–2030 ($MILLION)
FIGURE 26.COMPARATIVE ANALYSIS OF EP LABORATORY DEVICES ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2020–2030 (%)
FIGURE 27.ELECTROPHYSIOLOGY MARKET FOR CONVENTIONAL EP DIAGNOSTIC CATHETER, 2020–2030 ($MILLION)
FIGURE 28.ELECTROPHYSIOLOGY MARKET FOR STEERABLE DIAGNOSTIC CATHETERS, 2020–2030 ($MILLION)
FIGURE 29.ELECTROPHYSIOLOGY MARKET FOR FIXED DIAGNOSTIC CATHETERS, 2020–2030 ($MILLION)
FIGURE 30.ELECTROPHYSIOLOGY MARKET FOR ADVANCED EP DIAGNOSTIC CATHETERS, 2020–2030 ($MILLION)
FIGURE 31.ELECTROPHYSIOLOGY MARKET FOR ULTRASOUND EP DIAGNOSTIC CATHETERS, 2020–2030 ($MILLION)
FIGURE 32.COMPARATIVE ANALYSIS OF EP DIAGNOSTIC CATHETERS ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2020–2030 (%)
FIGURE 33.COMPARATIVE ANALYSIS OF ELECTROPHYSIOLOGY MARKET FOR ACCESS DEVICES, BY COUNTRY, 2020–2030 (%)
FIGURE 34.COMPARATIVE ANALYSIS OF OTHERS ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2020–2030 (%)
FIGURE 35.COMPARATIVE ANALYSIS OF ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION (AF), BY COUNTRY, 2020–2030 (%)
FIGURE 36.COMPARATIVE ANALYSIS OF ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY COUNTRY, 2020–2030 (%)
FIGURE 37.COMPARATIVE ANALYSIS OF ELECTROPHYSIOLOGY MARKET FOR WOLFF-PARKINSON-WHITE SYNDROME (WPW), BY COUNTRY, 2020–2030 (%)
FIGURE 38.COMPARATIVE ANALYSIS OF ELECTROPHYSIOLOGY MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT), BY COUNTRY, 2020–2030 (%)
FIGURE 39.COMPARATIVE ANALYSIS OF ELECTROPHYSIOLOGY MARKET FOR OTHERS, BY COUNTRY, 2020–2030 (%)
FIGURE 40.COMPARATIVE ANALYSIS OF ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS, BY COUNTRY, 2020–2030 (%)
FIGURE 41.COMPARATIVE ANALYSIS OF ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2020–2030 (%)
FIGURE 42.COMPARATIVE ANALYSIS OF ELECTROPHYSIOLOGY MARKET FOR OTHERS, BY COUNTRY, 2020–2030 (%)
FIGURE 43.ABBOTT: NET SALES, 2018–2020 ($MILLION)
FIGURE 44.ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 45.ABBOTT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 46.BOSTON SCIENTIFIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 47.BOSTON SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 48.BOSTON SCIENTIFIC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 49.GE HEALTHCARE: NET SALES, 2018–2020 ($MILLION)
FIGURE 50.GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 51.GE HEALTHCARE: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 52.PHILIPS: NET SALES, 2018–2020 ($MILLION)
FIGURE 53.PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 54.PHILIPS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 55.J&J: NET SALES, 2018–2020 ($MILLION)
FIGURE 56.J&J: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 57.J&J: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 58.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 59.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 60.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 61.MICROPORT: NET SALES, 2018–2020 ($MILLION)
FIGURE 62.MICROPORT: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 63.MICROPORT: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 64.SIEMENS: NET SALES, 2019–2021 ($MILLION)
FIGURE 65.SIEMENS: REVENUE SHARE, BY SEGMENT, 2021 (%)
FIGURE 66.SIEMENS: REVENUE SHARE, BY REGION, 2021 (%)

ページTOPに戻る

Table of Contents

Summary

The global electrophysiology market was valued at $6,499.7 million in 2020, and is estimated to reach $22,651.4 million by 2030, growing at a CAGR of 14.4% from 2021 to 2030.

Electrophysiology is defined as the study of the mechanism and performance of electrical signaling pathway that guides functioning of heartbeats. It is a procedure used to diagnose cardiac arrhythmia by identifying area of heart tissue, which disturbs normal functioning of the heart’s electrical system. Electrophysiology device is also designed to treat atrial fibrillation by surgical removal of abnormal tissue in the heart through catheter.

Growth of the global electrophysiology market is majorly driven by an alarming increase in prevalence of cardiac arrhythmia such as atrial fibrillation and atrial flutter; rise in government initiatives to spread awareness & promote knowledge to physicians and electrophysiologists about handling and use of electrophysiology devices; and surge in number of cardiac ablation procedures. For instance, in 2021, APN health, a next generation medical device company, reported that approximately 750,000 cardiac electrophysiology ablation procedure were conducted in the U.S. Moreover, as per the same source, in 2021, it was also observed that around 300,000 number of catheter ablation procedures are conducted for atrial fibrillation. Moreover, in August 2021, Medline ReNewal, one of the leading medical device reprocessing sectors, announced launch of continuing education course series to help cardiac electrophysiology clinicians to learn more about fundamentals of cardiac electrophysiology laboratory procedures.

In addition, advancements in technology to develop electrophysiology catheters and increase in strategic agreements to enhance electrophysiology products are major factors that drive the global electrophysiology market. For instance, in January 2022, Medtronic, Inc., one of the leading healthcare technology companies, announced an agreement with Affera, Inc. to enhance the portfolio of advanced cardiac ablation products and accessories. Moreover, increase in prevalence of chronic diseases such as diabetics, cardiovascular diseases, and hypertension significantly contributes toward the market growth.

Furthermore, rise in number of geriatric populations drive growth of the market. This is attributed to the fact that geriatric population is highly vulnerable to cardiac diseases such as atrial fibrillation, owing to aging effect, which boosts demand for various electrophysiology catheters for better health outcomes. According to the National Center for Chronic Disease Prevention and Health Promotion, it was reported that around 9% of population above the age of 65 years are diagnosed with atrial fibrillation. This factor is expected to notably contribute toward growth of the global electrophysiology market.

Rise in number of approvals of electrophysiology devices such as ablation catheters and diagnostic catheters acts as a key driving force for the global market. Furthermore, rise in funds by governments of various countries and private organizations to cardiac centers and healthcare infrastructure are expected to boost the market growth. In addition, increase in healthcare expenditure and increase in number of key players that manufacturer advanced and innovative devices to provide lucrative opportunities for the market expansion.

However, high cost associated with electrophysiology devices hinders the market growth. On the contrary, increase in number of clinical studies on cardiac ablation augments growth of the electrophysiology market. For instance, in 2020, Biosense Webster, a part of Johnson & Johnson family of companies, conducted an alteplase-tenecteplase trial evaluation for stroke thrombolysis (ATTEST) clinical study to evaluate that the result between radiofrequency (RF) ablation procedure and anti-arrhythmia therapy alone to delay progression of persistent atrial fibrillation. The result concluded that RF ablation procedure is more effective then drug in the patient diagnosed with paroxysmal to persistent AF. This has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities for expansion of the electrophysiology market.
The global electrophysiology market is segmented into product, indication, end user, and region. By product, the market is categorized into EP ablation catheters, EP laboratory devices, EP diagnostic catheters, access devices, and others. Depending on indication, it is fragmented into atrial fibrillation (AF), atrial flutter, Wolff-Parkinson-White syndrome (WPW), atrioventricular nodal reentry tachycardia (AVNRT), and others. On the basis end user, it is segregated into hospitals & cardiac centers, ambulatory surgery centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global electrophysiology market are Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, CardioFocus, Inc., GE Healthcare, Koninklijke Philips N.V., Johnson & Johnson, Inc., Medtronic Plc., MicroPort Scientific Corporation, and Siemens Healthineers AG.

KEY BENEFITS FOR STAKEHOLDERS

 The report provides an in-depth analysis of the global electrophysiology market size along with the current trends and future estimations to elucidate the imminent investment pockets.
 It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
 A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
 The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global electrophysiology market.

KEY MARKET SEGMENTS
#By Product
##EP Ablation Catheters
###Cryoablation EP catheters
###Radiofrequency Ablation Catheters
####Irrigated-Tip Radiofrequency Ablation Catheters
####Conventional Radiofrequency Ablation Catheters
###Microwave Ablation Systems
###Laser Ablation Systems
###Navigational Advanced Mapping Accessories
##EP Laboratory Devices
###EP X-Ray Systems
###3D Mapping Systems
###EP Recording Systems
###EP Remote Steering Systems
###EP Remote Steering Systems
###Others
##EP Diagnostic Catheters
###Conventional EP Diagnostic Catheters
####Steerable Diagnostic Catheters
####Fixed Diagnostic Catheters
###Advanced EP Diagnostic Catheters
###Ultrasound EP Diagnostic Catheters
##Access Devices
##Others

#By Indication
##Atrial Fibrillation (AF)
##Atrial Flutter
##Wolff-Parkinson-White Syndrome (WPW)
##Atrioventricular Nodal Reentry Tachycardia (AVNRT)
##Others
#By End User
##Hospitals & Cardiac Centers
##Ambulatory Surgery Centers
##Others

#By Region
##North America
###U.S.
###Canada
###Mexico
##Europe
###Germany
###France
###UK
###Italy
###Rest of Europe
##Asia-Pacific
###Japan
###China
###Australia
###India
###Rest of Asia-Pacific
##LAMEA
###Brazil
###Saudi Arabia
###South Africa
###Rest of LAMEA

KEY MARKET PLAYERS
#Abbott Laboratories
#Biotronik SE & Co. KG
#Boston Scientific Corporation
#CardioFocus, Inc.
#GE Healthcare
#Koninklijke Philips N.V.
#Johnson & Johnson, Inc.
#Medtronic Plc.
#MicroPort Scientific Corporation
#Siemens Healthineers AG

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（atrial fibrillation）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（atrial fibrillation）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?